In this study, the investigators will evaluate the efficacy of Bladder Thermal Distention (BTD) in patients with overactive bladder syndrome who failed previous treatment of anticholinergic drugs. The investigators' hypothesis is that it will improve the storage symptoms.
Inclusion criteria: 1. Patients with overactive bladder syndrome 2. Detrusor Overactivity proven in urodynamic test Exclusion criteria: 1. Mixed urinary incontinence 2. Active urinary tract infection 3. Urethral Stricture Outcome measures: 1. Bladder Diaries 2. Urgency questionnaire
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
20
Bladder Thermal Distention is an approved procedure in Europe from 2006. The treatment is hydrodistention of the bladder with a warm saline (up to 45C). The procedure lasts 1 hour. The saline is infused constantly through a 3 ways specific catheter (Unithermia 18F) by the PelvixTT system.
Assaf Harofe MC
Tel Aviv Region, Zeriffin, Israel
RECRUITINGUrgency Questionnaire
Patients will complete the validated USIQ questionnaire
Time frame: up to 1 year
Daily frequency of micturitions on Bladder Diary
Patients will complete bladder diaries before and after the procedure. Frequencies of micturitions per day will be documented
Time frame: up to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.